Pharmafile Logo
Pharmafocus logo
Advanced Search

pharmaceuticals

Showing 15 posts of 68 posts found.

nih_logo

NIH funds research into infant opioid withdrawal syndrome treatment

October 3, 2017
Manufacturing and Production, Research and Development NIH, National Institutes of Health, opioid crisis, opioids, pharma, pharmaceuticals

As the US continues to be plagued by its opioid crisis, which is claiming the lives of more than 100 …

News
fda2outsideweb

Makers of immediate-release opioids must fund training on their use, FDA says

September 29, 2017
Medical Communications FDA, OxyContin, opioids, pharma, pharmaceuticals, vicodin

As part of its ongoing response to the opioid crisis in the US which is claiming the lives of over …

News
brexit_flag

EMA relocation will cause drug approval delays even in best case scenario, agency says

September 27, 2017
Research and Development EMA, brexit, pharma, pharmaceuticals

As a direct result of the UK’s referendum vote to leave the EU last year, the headquarters of the EMA, …

News
shutterstock_57369385

Refining the system: Improving patients’ access to medicine

September 25, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NCIE, drug access, eams, market access, pharma, pharmaceuticals

The MHRA and NICE have been slowly improving the ways that the UK’s patients access medicines, but now Brexit threatens …

Feature
janssen_latest_logo_on_sign_closer

Janssen reveals positive CHMP opinion, long-term data for psoriasis drug guselkumab

September 19, 2017
Manufacturing and Production, Research and Development, Sales and Marketing EMA< CHMP, Janssen, guselkumab, pharma, pharmaceuticals

Janssen has announced that its psoriasis drug guselkumab has been awarded a positive opinion by the EMA’s Committee for Medicinal …

News
fosun_pharma

China’s Fosun Group grabs 74% stake in India’s Gland Pharma for $1.1 billion

September 18, 2017
Sales and Marketing China, Fosun Pharma, Gland Pharma, India, pharma, pharmaceuticals

Chinese conglomerate Fosun has agreed to acquire 74% of India’s Gland Pharma for $1.1 billion, sealing a previously unsuccessful deal …

News
narasimhan_2

Novartis exec designated as new CEO after Jimenez announces retirement

September 5, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Novartis, a, joe jimenez, phar, pharma, pharmaceuticals

Novartis has announced that its Chief Executive, Joe Jimenez, is set to retire next year. In his place, Vasant Narasimhan …

Appointment
mr058666-web

Merck KGaA commits to continued partnership with Ugandan Government

September 5, 2017
Manufacturing and Production, Medical Communications Merck, infertility, life sciences, pharma, pharmaceuticals, uganda

Merck KGaA has revealed plans to continue its commitment to a key partnership with the Ugandan Government via its non-profit …

News
novartis_side_building

Novartis celebrates success of Gilenya in paediatric multiple sclerosis

September 5, 2017
Manufacturing and Production, Research and Development MS, Novartis, gilenya, health, multiple sclerosis, pharma, pharmaceuticals

Novartis has announced results of its Phase 3 study investigating the safety and efficacy of Gilenya (fingolimod) , finding that …

News
asthma

Asthma drugs reduce Parkinson’s risk by 50%, decade-long study finds

September 5, 2017
Manufacturing and Production, Research and Development Parkinson's, Parkinson's disease, asthma, pharma, pharmaceuticals, salbutamol

A study from the Department of Global Public Health and Primary Care at the University of Bergen (UiB) in Norway …

News
entrance_takeda_i020_v1

Takeda partners up to develop “next generation” CAR T solid tumour therapy

September 4, 2017
Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, Noile-Immune, Takeda, pharma, pharmaceuticals

Takeda is set to partner with Noile-Immune Biotech in the development of a “next generation” chimeric antigen receptor T-cell (CAR …

News
joseph_jimenez

Novartis CEO Jimenez announces retirement in 2018

September 4, 2017
Sales and Marketing Novartis, Vasant Narasimhan, joe jimenez, pharma, pharmaceuticals

Novartis has announced that its Chief Executive, Joe Jimenez (pictured), is set to retire next year. In his place, Vasant …

News
virginia-7592

Has Trump’s power over pharma come to an end after Charlottesville?

August 31, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Donald Trump, J&J, JJ, Kenneth Frazier, MSD, President trump, Trump, life sciences, medicine, pharma, pharmaceuticals, president

In a shock move that was to have deeply resonant consequences, MSD Chairman and Chief Executive Officer Kenneth Frazier announced …

Feature
teva

Teva scores expanded indication for Austedo in tardive dyskinesia

August 31, 2017
Sales and Marketing FDA, Teva, medicine, pharma, pharmaceuticals

Following the FDA’s approval of Teva’s Austedo (deutetrabenazine) in the treatment of chorea associated with Huntington’s disease in April this …

News
shutterstock_212035546

Immunotherapy firm develops breakthrough method for robust bispecific antibody production

August 30, 2017
Research and Development antibodies, immunotherapy, merus, pharma, pharmaceuticals

A team of researchers at Dutch immunotherapy research firm Merus have developed an approach to efficiently manufacture bispecific antibodies which …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025